Diabetes Simplified 2020 Enduring

Diabetes Simplified – Practical Recommendations to Improve Patient Care

Diabetes-Simplified-logo
Diabetes Canada 2020 Pharmacotherapy Chapter Update
Description

Diabetes Canada 2020 Pharmacotherapy Chapter Update

Practical review and explanation of the pharmacotherapy in type 2 diabetes 2020 guideline chapter update 

Learning Objectives

  1. Review the key changes in the Diabetes Canada 2020 pharmacotherapy in type 2 diabetes chapter of the guidelines
  2. Determine the patient and agent factors that should be considered when initiating antihyperglycemic pharmacotherapy in type 2 diabetes
  3. Discuss how primary care clinicians can integrate these recommendations for managing patients with type 2 diabetes in their practices

Planning Committee

  • Peter Senior, MBBD, PhD, FRCP
  • James Kim, MBBCh, PgDip
  • Maureen Clement, MD, CCFP
  • Peter J. Lin, MD, CCFP

Video Speaker

James Kim, MBBCh, PgDip

Cardiovascular Considerations for the Diabetes Patient 

Cardiovascular Considerations for the Diabetes Patient 

2020 guideline update on how to reduce CVD risk with antihyperglycemic agents.

Learning Objectives

  1. Review the importance of cardiovascular disease protection in people with diabetes
  2. Apply Diabetes Canada’s ABCDESSS mnemonic to reducing cardiovascular risk
  3. Determine the optimal therapy to reduce the patient’s cardiovascular risk

Planning Committee

  • Alice Y. Y. Cheng, MD, FRCPC
  • Peter J. Lin, MD, CCFP
  • James Kim, MBBCh, PgDip
  • Maureen Clement, MD, CCFP

Video Speaker

Peter J. Lin, MD, CCFP

The Role Of Allied Health Diabetes Care Team

The Role Of Allied Health Diabetes Care Team

The diabetes care team can improve outcomes. This module reviews the role of nurse educators, dietitians, and pharmacists 

Learning Objectives

  1. Review the importance of interprofessional collaboration in diabetes management
  2. Discuss the benefits of referral and utilization of different primary care health care professional for patients with diabetes
  3. Provide patients with easy suggestions that can improve diabetes management

Planning Committee

  • Lori Berard, Nurse Consultant
  • Piraveena Piremathasan, P.Dt, CDE, CBE
  • Michael Boivin, B. Pharm, CDE, CTE, CTH
  • James Kim, MBBCh, PgDip
  • Maureen Clement, MD, CCFP
  • Peter J. Lin, MD, CCFP

Video Speaker

Lori Berard, Nurse Consultant

Renal Protection in the Diabetes Patient

Renal Protection in the Diabetes Patient

Learn about strategies to improve outcomes in people with type 2 diabetes and CKD.

Learning Objectives

  1. Review the guideline recommended assessment of renal function in people with type 2 diabetes
  2. Discuss the prevalence and impact of chronic kidney disease in people with diabetes
  3. Initiate therapy in people with diabetes and CKD that has been shown to improve renal outcomes

Planning Committee

  • Louis Girard, MD, MBT, FRCPC
  • Maureen Clement, MD, CCFP
  • James Kim, MBBCh, PgDip
  • Peter J. Lin, MD, CCFP

Video Speaker

Maureen Clement, MD, CCFP

Hypoglycemia in the Diabetes Patient

Hypoglycemia in the Diabetes Patient

Hypoglycemia is a major barrier to optimal control. This module updates you on recent advancements.

Learning Objectives

  1. Determine the prevalence and risk factors for hypoglycemia
  2. Review the guideline recommended management of hypoglycemia
  3. Address hypoglycemia unawareness and nocturnal hypoglycemia in clinical practice

Planning Committee

  • Stewart Harris, CM, MD, MPH, FCFP, FACPM
  • Alexandria Ratzki-Leewing, MSc, PhD(c)
  • James Kim, MBBCh, PgDip
  • Maureen Clement, MD, CCFP
  • Peter J. Lin, MD, CCFP

Video speaker

Stewart Harris, CM, MD, MPH, FCFP, FACPM

Glucose Monitoring Considerations and Recommendations  

Glucose Monitoring Considerations and Recommendations 

Learn more of the current monitoring technology and how it can improve diabetes care. 

Learning Objectives

  1. Review the different methods of monitoring glucose level in people with diabetes
  2. Customize the self-monitoring glucose device for a person with diabetes
  3. Determine how new monitoring technology is improving outcomes in people with diabetes

Planning Committee

  • Akshay Jain, MD, FRCPC, FACE, CCD, ECNU, DABIM, DABOM
  • Rick Siemens, B.Sc. Pharm., B.Sc. Biol., CDE, CPT
  • James Kim, MBBCh, PgDip
  • Maureen Clement, MD, CCFP
  • Peter J. Lin, MD, CCFP

Video Speaker

Akshay Jain, MD, FRCPC, FACE, CCD, ECNU, DABIM, DABOM

Partners

IN COLLABORATION WITH

PPME Logo

ENDORSED BY

Diabetes Canada Logo

Sponsors

Novo Nodisk Logo
Sanofi